ArticleJournal of cellular and molecular medicine2026

Ruxolitinib Penetrates Blood Brain Barrier and Reduces the Cytokine Storm in Patients With Haemophagocytic Lymphohistiocytosis.

Wenjun Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.